DFO
MLTX icon

Duquesne Family Office’s MoonLake Immunotherapeutics MLTX Stock Holding History

Duquesne Family Office’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-87,500
Closed -$4.4M – 78
2024
Q1 		$4.4M Buy
+87,500
New +$4.4M 0.1% 65